Page 4 - Cc Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Equities Research Analysts’ updated eps estimates for Thursday, April 4th: Arbutus Biopharma (NASDAQ:ABUS) had its market outperform rating reaffirmed by analysts at JMP Securities. JMP Securities currently has a $4.00 price target on the stock. Arcellx (NASDAQ:ACLX) had its outperform rating reaffirmed by analysts at Scotiabank. The firm currently has a $82.00 target price on […]

C&C Group (LON:CCR – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Shore Capital in a report released on Thursday, MarketBeat.com reports. C&C Group Trading Up 0.1 % LON:CCR traded up GBX 0.20 ($0.00) during trading hours on Thursday, reaching GBX 165.20 ($2.07). 292,718 shares of the company were exchanged, […]

C&C Group plc (OTCMKTS:CGPZF – Get Free Report) was the recipient of a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 108,600 shares, a decline of 19.4% from the February 29th total of 134,800 shares. Based on an average daily trading volume, of 200 […]

The shortlist has now been announced for the prestigious E Awards – the country's only night celebrating the country's events and festivals…

C&C Group plc (LON:CCR – Get Free Report)’s stock price reached a new 52-week high on Tuesday . The stock traded as high as GBX 161.20 ($2.04) and last traded at GBX 160.40 ($2.03), with a volume of 464397 shares trading hands. The stock had previously closed at GBX 158.20 ($2.00). Wall Street Analysts Forecast […]